SR

Seetha Raman Subramaniyam

Active Director Managing Director DIN 06364310
DIN 06364310 First appointment Jul 2013 Primary industry Business Outsourcing
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Jul 2013
Shareholding value •••• Premium profile

About Seetha Raman Subramaniyam

Data last updated:

Seetha Raman Subramaniyam is a Managing Director at Response Informatics Limited (since 2019), Director at Elegant Drugs Private Limited (since 2022) and Director at Ariston Tek Solutions Private Limited (since 2013). The companies operate in Business Outsourcing, Pharma and Information Technology. The 3 current companies with reported revenue have a combined latest revenue of ₹38.86 Cr; the largest is Response Informatics Limited at ₹33.72 Cr (FY 2025). Earlier, Seetha Raman Subramaniyam was an Additional Director at Psi Formulations Private Limited (2017–2018).

DIN 06364310
Primary Designation Managing Director
Industry Business Outsourcing
First Appointment 29 Jul 2013
Oldest Company Age 38 yrs
Largest company Response Informatics Limited · ₹33.72 Cr (FY 2025)
Combined revenue ₹38.86 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Response Informatics Limited L72200TG1996PLC025871
Managing Director31 Jan 20191996₹33.72 Cr (FY 2025)Active
Elegant Drugs Private Limited U02423KA1988PTC009345
Director13 Jan 20221988₹4.12 Cr (FY 2025)Active
Director29 Jul 20132008₹1.03 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Psi Formulations Private Limited U24304TG2017PTC116134
Additional Director28 Aug 20172017Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Response Informatics Limited
Ariston Tek Solutions Private Limited
Elegant Drugs Private Limited
Psi Formulations Private Limited
Premium access

Shareholding and investment profile for Seetha Raman Subramaniyam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seetha Raman Subramaniyam

Seetha Raman Subramaniyam currently holds 3 directorships: Response Informatics Limited (Managing Director, since 31 Jan 2019, revenue ₹33.72 Cr (FY 2025)); Elegant Drugs Private Limited (Director, since 13 Jan 2022, revenue ₹4.12 Cr (FY 2025)); Ariston Tek Solutions Private Limited (Director, since 29 Jul 2013, revenue ₹1.03 Cr (FY 2024)).

Seetha Raman Subramaniyam was first appointed on 29 Jul 2013 as Director at Ariston Tek Solutions Private Limited. The most recent appointment on record is 13 Jan 2022 at Elegant Drugs Private Limited.

The 3 current companies of Seetha Raman Subramaniyam that report revenue have a combined latest revenue of ₹38.86 Cr: Response Informatics Limited ₹33.72 Cr (FY 2025); Elegant Drugs Private Limited ₹4.12 Cr (FY 2025); Ariston Tek Solutions Private Limited ₹1.03 Cr (FY 2024).

Seetha Raman Subramaniyam held 1 earlier board appointment: Psi Formulations Private Limited (Additional Director, 28 Aug 2017 to 22 Jan 2018).

The current boards of Seetha Raman Subramaniyam's companies include Ashwini Mangalampalle (Response Informatics Limited), Bhuvaneswari Seetharaman (Response Informatics Limited), Chandra Sekhar Pattapurathi (Response Informatics Limited), Prakash Babu Kondeti (Response Informatics Limited), Ramakrishna Prasad Makkena (Response Informatics Limited), Koteswara Rao Yechuri (Elegant Drugs Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available